NELFCD
Negative elongation factor C/D
Also known as: HSPC130, NELF-C, NELF-D, NELFD_HUMAN, TH1, TH1L
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IXH7
- Gene
- NELFCD
- Ensembl
- ENSG00000101158
- Chromosome
- 20
- Canonical length
- 590 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Vesicles,Cytosol
OverviewNCBI Gene
The NELF complex of proteins interacts with the DSIF protein complex to repress transcriptional elongation by RNA polymerase II. The protein encoded by this gene is an essential part of the NELF complex. Alternative translation initiation site usage results in the formation of two isoforms with different N-termini. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
590 residues, UniProt reviewed canonical sequence.
>Q8IXH7|NELFCD
1 MAGAVPGAIM DEDYYGSAAE WGDEADGGQQ EDDSGEGEDD AEVQQECLHK FSTRDYIMEP
61 SIFNTLKRYF QAGGSPENVI QLLSENYTAV AQTVNLLAEW LIQTGVEPVQ VQETVENHLK
121 SLLIKHFDPR KADSIFTEEG ETPAWLEQMI AHTTWRDLFY KLAEAHPDCL MLNFTVKLIS
181 DAGYQGEITS VSTACQQLEV FSRVLRTSLA TILDGGEENL EKNLPEFAKM VCHGEHTYLF
241 AQAMMSVLAQ EEQGGSAVRR IAQEVQRFAQ EKGHDASQIT LALGTAASYP RACQALGAML
301 SKGALNPADI TVLFKMFTSM DPPPVELIRV PAFLDLFMQS LFKPGARINQ DHKHKYIHIL
361 AYAASVVETW KKNKRVSINK DELKSTSKAV ETVHNLCCNE NKGASELVAE LSTLYQCIRF
421 PVVAMGVLKW VDWTVSEPRY FQLQTDHTPV HLALLDEIST CHQLLHPQVL QLLVKLFETE
481 HSQLDVMEQL ELKKTLLDRM VHLLSRGYVL PVVSYIRKCL EKLDTDISLI RYFVTEVLDV
541 IAPPYTSDFV QLFLPILEND SIAGTIKTEG EHDPVTEFIA HCKSNFIMVNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NELFCD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 33 nTPM
- pituitary gland: 32 nTPM
- skeletal muscle: 30 nTPM
- kidney: 30 nTPM
- retina: 30 nTPM
- thymus: 29 nTPM
Single-cell type
- cytotrophoblasts: 167 nCPM
- migrating cytotrophoblasts: 123 nCPM
- syncytiotrophoblasts: 117 nCPM
- differentiating spermatogonia: 102 nCPM
- somatotrophs: 101 nCPM
- undifferentiated spermatogonia: 100 nCPM
Immune cell
- non-classical monocyte: 69 nTPM
- myeloid DC: 65 nTPM
- intermediate monocyte: 52 nTPM
- memory CD8 T-cell: 51 nTPM
- MAIT T-cell: 50 nTPM
- total PBMC: 49 nTPM
Brain region
- white matter: 29 nTPM
- basal ganglia: 26 nTPM
- medulla oblongata: 25 nTPM
- cerebellum: 24 nTPM
- thalamus: 24 nTPM
- pons: 24 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.44
- gnomAD pLI
- 0.18
- gnomAD missense Z
- 2.29
- DepMap mean gene effect
- -0.62
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 18% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- TH1 protein
- TH1 protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NELFCD in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NELFCD as an antibody target. Whether an autoantibody or antibody against NELFCD could matter depends on whether native NELFCD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NELFCD is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NELFCD as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...